Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Clezardin

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Anti-Cancer Agents in Medicinal Chemistry|August 26, 2011
Potential anticancer properties of bisphosphonates: insights from preclinical studiesPhilippe Clezardin
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 10, 2012
Bioluminescence imaging of prenylation inhibition--letterPhilippe Clezardin
Clinical & Experimental Metastasis|November 17, 2007
Bone metastasis: pathogenesis and therapeutic implicationsPhilippe Clezardin, Anna Teti
Journal of the National Cancer Institute|July 4, 2012
Effects of bone-targeted agents on cancer progression and mortalityRobert Coleman, Michael Gnant, Gareth Morgan, et al.
The Journal of Biological Chemistry|September 5, 2003
Angiostatin inhibits bone metastasis formation in nude mice through a direct anti-osteoclastic activityOlivier Peyruchaud, Claire-Marie Serre, Roisin NicAmhlaoibh, et al.
European Journal of Cancer (Oxford, England : 1990)|January 30, 2007
International Society of Geriatric Oncology (SIOG) clinical practice recommendations for the use of bisphosphonates in elderly patientsJean-Jacques Body, Rob Coleman, Philippe Clezardin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2008
Differential effect of doxorubicin and zoledronic acid on intraosseous versus extraosseous breast tumor growth in vivoPenelope D Ottewell, Blandine Deux, Hannu Mönkkönen, et al.
Anticancer Research|December 11, 2012
Overexpression of CD9 in human breast cancer cells promotes the development of bone metastasesPhilippe Kischel, Akeila Bellahcene, Blandine Deux, et al.
Cancers|July 27, 2022
Impact of Anti-Angiogenic Treatment on Bone Vascularization in a Murine Model of Breast Cancer Bone Metastasis Using Synchrotron Radiation Micro-CTHao Xu, Marie-Hélène Lafage-Proust, Lamia Bouazza, et al.
Cells|March 6, 2021
Knockdown of AKT3 Activates HER2 and DDR Kinases in Bone-Seeking Breast Cancer Cells, Promotes Metastasis In Vivo and Attenuates the TGFβ/CTGF AxisNico Hinz, Anke Baranowsky, Michael Horn, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Anti-Cancer Agents in Medicinal Chemistry|August 26, 2011
Potential anticancer properties of bisphosphonates: insights from preclinical studiesPhilippe Clezardin
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 10, 2012
Bioluminescence imaging of prenylation inhibition--letterPhilippe Clezardin
Clinical & Experimental Metastasis|November 17, 2007
Bone metastasis: pathogenesis and therapeutic implicationsPhilippe Clezardin, Anna Teti
Journal of the National Cancer Institute|July 4, 2012
Effects of bone-targeted agents on cancer progression and mortalityRobert Coleman, Michael Gnant, Gareth Morgan, et al.
The Journal of Biological Chemistry|September 5, 2003
Angiostatin inhibits bone metastasis formation in nude mice through a direct anti-osteoclastic activityOlivier Peyruchaud, Claire-Marie Serre, Roisin NicAmhlaoibh, et al.
European Journal of Cancer (Oxford, England : 1990)|January 30, 2007
International Society of Geriatric Oncology (SIOG) clinical practice recommendations for the use of bisphosphonates in elderly patientsJean-Jacques Body, Rob Coleman, Philippe Clezardin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2008
Differential effect of doxorubicin and zoledronic acid on intraosseous versus extraosseous breast tumor growth in vivoPenelope D Ottewell, Blandine Deux, Hannu Mönkkönen, et al.
Anticancer Research|December 11, 2012
Overexpression of CD9 in human breast cancer cells promotes the development of bone metastasesPhilippe Kischel, Akeila Bellahcene, Blandine Deux, et al.
Cancers|July 27, 2022
Impact of Anti-Angiogenic Treatment on Bone Vascularization in a Murine Model of Breast Cancer Bone Metastasis Using Synchrotron Radiation Micro-CTHao Xu, Marie-Hélène Lafage-Proust, Lamia Bouazza, et al.
Cells|March 6, 2021
Knockdown of AKT3 Activates HER2 and DDR Kinases in Bone-Seeking Breast Cancer Cells, Promotes Metastasis In Vivo and Attenuates the TGFβ/CTGF AxisNico Hinz, Anke Baranowsky, Michael Horn, et al.
Pageof 3